DNASE1 and cystic fibrosis: Similarly, respiratory therapies leverage PLGA for delivering therapeutic proteins like Deoxyribonuclease I (DNaseI), which breaks down extracellular DNA in lung secretions to improve respiratory function in cystic fibrosis by enhancing mucus clearance [37].